Skip to main content
OpenTrials
Completed

NCT Number: NCT03852862

Double Regional Anesthesia in Video Assisted Thoracoscopy

Monocentric, randomized, controlled, single-blind study who's aim is to demonstrate the efficacy of the association of paravertebral block and serratus plane block with paravertebral block alone

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Video Assisted Thoracoscopy Anesthesia

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Rouen University Hospital

Rouen, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient aged 18 to 75 years;
  • Programmed for unilateral videothoracoscopy for anatomical resection (segmentectomy, lobectomy);
  • Subject affiliated to a social security scheme;
  • Subject having signed an informed consent

Exclusion criteria

  • Chronic treatment with opiates;
  • Contraindication to administration of morphine;
  • Allergy to local anesthetics or contraindications to the use of ropivacaine;
  • Contraindication to the realization of paravertebral blocks and serratus;
  • Pregnancy, breastfeeding;
  • Severe obesity (BMI > 40 kg/m²);
  • Renal impairment (GFR < 30 mL/min) or known severe hepatic impairment;
  • Difficulties of comprehension preventing the collection of consent and the realization of the study;

Treatment and study plan

Serratus plane block and paravertebral block

Drug

Single Administration of 20 mL of ropivacaine for Serratus plane block (Intra-muscular injection) followed by a single administration of 20 ml ropivacaine for paravertebral block (T4 inter-vertebral injection)

paravertebral block

Drug

Single Administration of 20 ml of ropivacaine for paravertebral block (T4 inter-vertebral injection)

Primary outcomes

  1. Number of opioids drug administrated

    Time frame: 24 hours postoperatively

Secondary outcomes

  1. Length of stay in recovery room

    Time frame: 24 hours postoperatively

  2. Total duration of hospitalization

    Time frame: during the 28 days postoperatively

Sponsors and collaborators

Lead sponsor

University Hospital, Rouen

Other

Registry information

Acronym: DRAVATS

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Feb 25, 2019
Registry last updated
Apr 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.